Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +40.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Trade receivables changed -31.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +59.6% from the comparable as-filed period.
Current liabilities changed -9.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +61.6% from the comparable as-filed period.
Operating margin changed +421 basis points from the comparable as-filed period.
Operating income changed +29.3% from the comparable as-filed period.
Gross margin changed +139 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +23.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed +1.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Stock-based compensation changed +46.6% from the comparable as-filed period.
Working capital / assets changed +153 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed -5.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capital expenditure changed +32.5% from the comparable as-filed period.
Current ratio changed +6.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +1532 basis points from the comparable as-filed period.
Receivables / revenue changed -2271 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1473 basis points from the comparable as-filed period.
SBC / revenue changed +186 basis points from the comparable as-filed period.
Revenue changed -2.6% from the comparable as-filed period.
Cost of revenue changed -8.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +59 basis points from the comparable as-filed period.
Research & development changed +7.9% from the comparable as-filed period.
Current assets changed -3.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +94 basis points from the comparable as-filed period.
Working capital changed -60.8% from the comparable as-filed period.
Cash & equivalents changed -18.0% from the comparable as-filed period.
Working capital / assets changed -307 basis points from the comparable as-filed period.
Shares outstanding changed +1.6% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Current assets changed -10.3% from the comparable as-filed period.
Total assets changed -6.3% from the comparable as-filed period.
Current ratio changed -12.0% from the comparable as-filed period.
Trade receivables changed -9.0% from the comparable as-filed period.
Current liabilities changed +1.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.